Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 13Liver Neoplasms 6Neoplasm Metastasis 4Recurrence 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms 1Melanoma 1Lung Metastases 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 155Dexamethasone 141Rituximab 85fludarabine 80Lenalidomide 72Cytarabine 70Bortezomib 65fludarabine phosphate 63Gemcitabine 62venetoclax 55pomalidomide 53Etoposide 53pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Chemoembolization, Therapeutic × Clear all
NCT02631499 2015-12-22

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Fudan University

Phase 4 Unknown
256 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡